植物・植物由来医薬品市場は2023年から2028年に209億3,000万米ドル、予測期間中のCAGRは8.18%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場を牽引しているのは、植物由来医薬品の使用を促進する政府のイニシアティブの高まり、従来の医薬品に伴う制約、慢性疾患の効果的な治療に対する需要の高まりなどです。
本調査では、アメリカにおける規制状況の変化が、今後数年間の市場情勢の成長を促進する主な要因の一つであるとしています。また、新たな医療分野に向けた医薬品開拓への注目の高まりや、革新的な製品を持つ新規参入企業の出現は、市場の大きな需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global botanical and plant-derived drugs market 2018 - 2022
4.2 Type Segment Analysis 2018 - 2022
4.3 Application Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by Type
6.1 Market segments
6.2 Comparison by Type
6.3 Oral - Market size and forecast 2023-2028
6.4 Injectables - Market size and forecast 2023-2028
6.5 Topicals - Market size and forecast 2023-2028
6.6 Market opportunity by Type
7 Market Segmentation by Application
7.1 Market segments
7.2 Comparison by Application
7.3 Infectious diseases - Market size and forecast 2023-2028
7.4 Central nervous system - Market size and forecast 2023-2028
7.5 Cardiovascular diseases - Market size and forecast 2023-2028
7.6 Respiratory diseases - Market size and forecast 2023-2028
7.7 Digestive diseases and others - Market size and forecast 2023-2028
7.8 Market opportunity by Application
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 Asia - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 North America - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 China - Market size and forecast 2023-2028
9.9 Germany - Market size and forecast 2023-2028
9.10 UK - Market size and forecast 2023-2028
9.11 Japan - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Bausch Health Companies Inc.
12.4 Bayer AG
12.5 Boehringer Ingelheim International GmbH
12.6 Devonian Health Group Inc.
12.7 Dr. Willmar Schwabe GmbH and Co. KG
12.8 F. Hoffmann La Roche Ltd.
12.9 Jaguar Health Inc.
12.10 Jazz Pharmaceuticals Plc
12.11 Merck KGaA
12.12 Novartis AG
12.13 Pfizer Inc.
12.14 Pierre Fabre SA
12.15 Protalix Biotherapeutics Inc.
12.16 Sanofi SA
12.17 Sun Pharmaceutical Industries Ltd.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global botanical and plant-derived drugs market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Injectables - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Injectables - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Injectables - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Topicals - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Topicals - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Topicals - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Type ($ billion)
Exhibits47: Data Table on Market opportunity by Type ($ billion)
Exhibits48: Chart on Application - Market share 2023-2028 (%)
Exhibits49: Data Table on Application - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Application
Exhibits51: Data Table on Comparison by Application
Exhibits52: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Central nervous system - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Central nervous system - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Central nervous system - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Central nervous system - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Respiratory diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Respiratory diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Respiratory diseases - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Respiratory diseases - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Digestive diseases and others - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Data Table on Digestive diseases and others - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Chart on Digestive diseases and others - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Digestive diseases and others - Year-over-year growth 2023-2028 (%)
Exhibits72: Market opportunity by Application ($ billion)
Exhibits73: Data Table on Market opportunity by Application ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits112: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits113: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2023 and 2028
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Bausch Health Companies Inc. - Overview
Exhibits124: Bausch Health Companies Inc. - Business segments
Exhibits125: Bausch Health Companies Inc. - Key news
Exhibits126: Bausch Health Companies Inc. - Key offerings
Exhibits127: Bausch Health Companies Inc. - Segment focus
Exhibits128: Bayer AG - Overview
Exhibits129: Bayer AG - Business segments
Exhibits130: Bayer AG - Key news
Exhibits131: Bayer AG - Key offerings
Exhibits132: Bayer AG - Segment focus
Exhibits133: Boehringer Ingelheim International GmbH - Overview
Exhibits134: Boehringer Ingelheim International GmbH - Business segments
Exhibits135: Boehringer Ingelheim International GmbH - Key news
Exhibits136: Boehringer Ingelheim International GmbH - Key offerings
Exhibits137: Boehringer Ingelheim International GmbH - Segment focus
Exhibits138: Devonian Health Group Inc. - Overview
Exhibits139: Devonian Health Group Inc. - Product / Service
Exhibits140: Devonian Health Group Inc. - Key offerings
Exhibits141: Dr. Willmar Schwabe GmbH and Co. KG - Overview
Exhibits142: Dr. Willmar Schwabe GmbH and Co. KG - Product / Service
Exhibits143: Dr. Willmar Schwabe GmbH and Co. KG - Key offerings
Exhibits144: F. Hoffmann La Roche Ltd. - Overview
Exhibits145: F. Hoffmann La Roche Ltd. - Business segments
Exhibits146: F. Hoffmann La Roche Ltd. - Key news
Exhibits147: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits148: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits149: Jaguar Health Inc. - Overview
Exhibits150: Jaguar Health Inc. - Business segments
Exhibits151: Jaguar Health Inc. - Key offerings
Exhibits152: Jaguar Health Inc. - Segment focus
Exhibits153: Jazz Pharmaceuticals Plc - Overview
Exhibits154: Jazz Pharmaceuticals Plc - Product / Service
Exhibits155: Jazz Pharmaceuticals Plc - Key news
Exhibits156: Jazz Pharmaceuticals Plc - Key offerings
Exhibits157: Merck KGaA - Overview
Exhibits158: Merck KGaA - Business segments
Exhibits159: Merck KGaA - Key news
Exhibits160: Merck KGaA - Key offerings
Exhibits161: Merck KGaA - Segment focus
Exhibits162: Novartis AG - Overview
Exhibits163: Novartis AG - Business segments
Exhibits164: Novartis AG - Key offerings
Exhibits165: Novartis AG - Segment focus
Exhibits166: Pfizer Inc. - Overview
Exhibits167: Pfizer Inc. - Product / Service
Exhibits168: Pfizer Inc. - Key news
Exhibits169: Pfizer Inc. - Key offerings
Exhibits170: Pierre Fabre SA - Overview
Exhibits171: Pierre Fabre SA - Business segments
Exhibits172: Pierre Fabre SA - Key offerings
Exhibits173: Pierre Fabre SA - Segment focus
Exhibits174: Protalix Biotherapeutics Inc. - Overview
Exhibits175: Protalix Biotherapeutics Inc. - Product / Service
Exhibits176: Protalix Biotherapeutics Inc. - Key offerings
Exhibits177: Sanofi SA - Overview
Exhibits178: Sanofi SA - Business segments
Exhibits179: Sanofi SA - Key news
Exhibits180: Sanofi SA - Key offerings
Exhibits181: Sanofi SA - Segment focus
Exhibits182: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits183: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits184: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits185: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits186: Inclusions checklist
Exhibits187: Exclusions checklist
Exhibits188: Currency conversion rates for US$
Exhibits189: Research methodology
Exhibits190: Validation techniques employed for market sizing
Exhibits191: Information sources
Exhibits192: List of abbreviations
